| 4 minute read

Hormone replacement therapy (HRT) is entering a new era. As clinical understanding of hormone health evolves, so too does the conversation around safety, efficacy, and individualized care. What was once viewed with caution is now being reassessed through a more evidence-driven lens that is reshaping how healthcare providers and patients approach treatment.
Exogenous hormones — hormones that originate outside of the body and are introduced to supplement, replace, or balance endogenous, aka naturally-produced, hormones — are now widely prescribed by physicians to address a range of conditions like hypothyroidism, erectile dysfunction, adrenal hypofunction, and the symptoms of menopause. Advances in formulation science have expanded delivery options beyond traditional oral therapies to include transdermal preparations, troches, suppositories, creams, and injections, offering greater flexibility in how treatment is administered.
Access has never been broader, and demand continues to rise. The global HRT market is projected to grow at 5.8% annually between 2025 and 2033, with even stronger growth expected in Canada (7.8%) and Australia (8.7%). As interest increases, so does the need for personalized approaches — an area where compounded HRT plays a distinct role.
Hormones are powerful chemical messengers that influence multiple systems in the human body. Responses to hormone therapy vary significantly from person to person.
Anyone considering hormone replacement therapy should be aware of two key principles.
The first is that HRT is highly personal. Hormonal set points differ widely between individuals and are influenced by complex physiological feedback systems. Hormone therapy requires a tailored approach to meet each patient’s needs, as hormone levels and their interactions within the body may differ widely between individuals.
The second is that the delivery mechanism matters. Peer-reviewed research shows that different routes of administration may result in different metabolic and absorption profiles, which can impact safety.
Whether you are newly exploring HRT or have been using it for years, hormone therapy should always be approached with care and clinical oversight. Compounded HRT are not FDA-approved drugs. Rather they are created by compounding pharmacies following established pharmacy formulation and production procedures.
These considerations make compounded hormone therapy medications a valuable and viable option for many patients.
Unlike mass-produced medications, compounded therapies may be prepared in a wide variety of dosage forms and strengths as well as formulations with different ingredients. They are prescribed to meet the specific needs of an individual patient. This level of customization enables healthcare providers to fine-tune treatment in ways that standard marketed products may not readily allow for an individual patient.
Compounded HRT medications support personalization by allowing pharmacists create a variety of formulations to fulfill the physician’s individualized prescription. This flexibility allows the pharmacist to:
HRT compounding may also provide solutions during drug shortages when commercial products are unavailable, like the recent shortages of testosterone injections in the US and Australia . In situations like these, compounded hormone therapies may help patients maintain continuity of treatment when off-the-shelf commercial products are unavailable.
Under appropriate medical supervision, compounded hormone therapy has been used to support the management of conditions such as:
Many people will probably consider hormone therapy at some point in their lives. While its potential applications are broad, the effects of HRT can be unique to each person. Compounded hormone therapy offers the physician flexibility to tailor treatment to the needs of each patient’s unique physiology — something mass-produced HRT options cannot always provide.
To learn more about whether hormone replacement therapy may be right for you, speak with your physician or qualified healthcare provider.
Disclaimer: This blog is for general informational and educational purposes only and does constitute professional, regulatory, or medical advice. Any third-party sites referenced in this blog are not monitored or controlled by Medisca and Medisca shall not be held responsible or liable for any content resulting therefrom. Medisca is not liable for any loss or damage arising from the use of or reliance on this content. Medisca makes no guarantees regarding the accuracy or completeness of the information contained herein. At all times, the patient must speak with their physician or qualified healthcare provider to determine if compounding is the suitable treatment for them.